Related Experiment Video

Updated: Aug 24, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin

Christopher W Woods1, Allen C Cheng, Vance G Fowler

  • 1Clinical Microbiology, Durham Veterans Administration Medical Center, Durham, NC 27705, USA. woods004@mc.duke.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|April 20, 2004
PubMed

Insights

Managing infective endocarditis (IE) is becoming harder due to emerging vancomycin-reduced susceptible Staphylococcus aureus (SARV). This report details the strain characteristics and treatment of a patient with SARV IE.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Infective endocarditis (IE) poses significant clinical challenges.
  • The rise of antimicrobial resistance, particularly in Staphylococcus aureus, complicates treatment strategies.
  • Vancomycin is a critical antibiotic for treating serious Gram-positive infections, including IE.

Observation:

  • A patient presented with infective endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin (SARV).
  • This SARV strain presents a growing concern for clinical management in the United States and globally.
  • Strain characterization was performed to understand the specific genetic and phenotypic properties of the SARV isolate.

Findings:

  • Detailed characterization of the SARV strain was conducted.
  • The patient's treatment course for SARV IE was documented.
  • Successful management strategies for this challenging pathogen were explored.

Implications:

  • The emergence of SARV necessitates updated clinical guidelines for IE management.
  • Understanding SARV strain characteristics is crucial for developing effective therapeutic approaches.
  • This case highlights the need for ongoing surveillance and research into antimicrobial resistance in Staphylococcus aureus.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...